Chimeric Antigen Receptor T-Cell Therapy in Aggressive B-Cell Lymphoma

被引：2
|
作者：
Hamilton, Mark P. [1 ,2 ,3 ]
Miklos, David B. [1 ,2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Ctr Canc Cell Therapy, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Div Blood & Marrow Transplantat & Cellular Therapy, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 06期
关键词：
CAR T-cell; Large B-cell lymphoma; Aggressive lymphoma; CAR T-cell toxicity; CAR T-cell resistance; Review; CD19; NON-HODGKIN-LYMPHOMA; AXICABTAGENE CILOLEUCEL; DOSE-ESCALATION; OUTCOMES; RESPONSES; MULTICENTER; REMISSIONS; LEUKEMIA; IMPACT; TRIAL;
D O I：
10.1016/j.hoc.2023.05.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1053 / 1075
页数：23
相关论文
共 50 条
  • [41] Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma
    Salem, Dalia A.
    Maric, Irina
    Yuan, Constance M.
    Liewehr, David J.
    Venzon, David J.
    Kochenderfer, James
    Stetler-Stevenson, Maryalice
    LEUKEMIA RESEARCH, 2018, 71 : 106 - 111
  • [42] Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy
    Zhou, Linghui
    Feng, Youqin
    Hong, Ruimin
    Wei, Guoqing
    Zhang, Mingming
    Chang, Alex H.
    Huang, He
    Hu, Yongxian
    SCIENCE CHINA-LIFE SCIENCES, 2025,
  • [43] Acute Kidney Injury Following Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma in a Kidney Transplant Recipient
    Melilli, Edoardo
    Mussetti, Alberto
    Linares, Gabriela Sanz
    Ruella, Marco
    La Salette, Charette
    Savchenko, Alexandre
    Taco, Maria del Rosario
    Montero, Nuria
    Grinyo, Josep
    Fava, Alex
    Goma, Montse
    Meneghini, Maria
    Manonelles, Anna
    Cruzado, Josepmaria
    Sureda, Ana
    Bestard, Oriol
    KIDNEY MEDICINE, 2021, 3 (04) : 665 - 668
  • [44] Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
    Lin, John K.
    Muffly, Lori S.
    Spinner, Michael A.
    Barnes, James, I
    Owens, Douglas K.
    Goldhaber-Fiebert, Jeremy D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (24) : 2105 - +
  • [45] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
    Howell, Timothy A.
    Matza, Louis S.
    Jun, Monika P.
    Garcia, Jacob
    Powers, Annette
    Maloney, David G.
    PHARMACOECONOMICS-OPEN, 2022, 6 (03) : 367 - 376
  • [46] Impact of Extranodal Involvement on Outcomes with Chimeric Antigen Receptor T-Cell Therapy in B-Cell Non-Hodgkin Lymphoma
    Kumar, Vinod
    Alotaibi, Shaykhah
    Li, Zhuo
    Ayala, Ernesto
    Kharfan-Dabaja, Mohamed A.
    Iqbal, Madiha
    BLOOD, 2024, 144 : 5129 - 5130
  • [47] Chimeric Antigen Receptor T-Cell Therapy in Elderly Patients with Relapsed or Refractory Large B-Cell Lymphoma: A Multicenter Study
    Tun, Aung M.
    Patel, Romil
    St-Pierre, Frederique
    Ouchveridze, Evguenia
    Niu, Alex
    Obasi, Jennifer
    Rosenthal, Allison C.
    Pophali, Priyanka A.
    Fenske, Timothy S.
    Karmali, Reem
    Ahmed, Sairah
    Johnston, Patrick B.
    BLOOD, 2023, 142
  • [48] Health State Utilities for Adverse Events Associated with Chimeric Antigen Receptor T-Cell Therapy in Large B-Cell Lymphoma
    Timothy A. Howell
    Louis S. Matza
    Monika P. Jun
    Jacob Garcia
    Annette Powers
    David G. Maloney
    PharmacoEconomics - Open, 2022, 6 : 367 - 376
  • [49] Bullous and Exanthematous Lesions Associated With Chimeric Antigen Receptor T-Cell Therapy in a Patient With Diffuse Large B-Cell Lymphoma
    Hu, Yongxian
    Zheng, Weiyan
    Qiao, Jianjun
    Cui, Qu
    Zhu, Yuanyuan
    Chang, Alex H.
    Huang, He
    JAMA DERMATOLOGY, 2020, 156 (09) : 1026 - 1028
  • [50] A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
    Atrash, Shebli
    Moyo, Tamara K.
    ONCOTARGETS AND THERAPY, 2021, 14 : 2185 - 2201
12345